oldenGoldenDecoy's picture

    It's Prostate Screening Time: New Cancer Treatment Drug Slashes Prostate Cancer Death Risk By Nearly 40%

    Father's Day is June 18th... Most men know about this, but if not...

    161,000 Americans are diagnosed with Prostate Cancer every year, and it kills nearly 27,000 annually.

    What is screening for prostate cancer?
    Two tests are commonly used to screen for prostate cancer— Digital rectal exam (DRE): A doctor or nurse inserts a gloved, lubricated finger into the rectum to estimate the size of the prostate and feel for lumps or other abnormalities. Prostate specific antigen (PSA) test: Measures the level of PSA in the blood.Jul 18, 2016



    And for those who are fortunate enough to have top-tier health insurance...

    Cancer Treatment Drug Zytiga Slashes Prostate Cancer Death Risk By Nearly 40%

    Sy Mukherjee | Fortune
    Jun 05, 2017

    Johnson & Johnson's cancer treatment Zytiga significantly cut the death risk for newly-diagnosed, advanced prostate cancer patients by 38%, according to data unveiled at the ongoing American Society of Clinical Oncology (ASCO) annual meeting this weekend. The results are impressive enough to change the very shape of prostate cancer treatment, according to ASCO officials.

    Zytiga was first approved by the FDA in 2011 and has since been cleared to treat advanced prostate cancer in certain patients. But the new data could help J&J win a regulatory expansion allowing the drug to be used much earlier in the process. "Those results, maybe not from an investor standpoint, but from a general standpoint, were pretty impressive," biotech investor and cancer immunotherapy fund runner Brad Loncar told Fortune in an interview.

    Prostate cancer is one of the largest oncology markets. It's the most common cancer afflicting men other than skin cancer, is diagnosed in more than 161,000 Americans every year, and kills nearly 27,000 annually (making it the third deadliest cancer for American men), according to the American Cancer Society.

    And, as Reuters reports, the therapy could prove even more promising for patients outside the U.S. who typically don't have the same kind of access to prostate cancer screenings.



    Through love of baseball... I Stand Up...

    Stand Up to Cancer MLB.org




    Glad you posted this, OGD.  It is very important.

    Latest Comments